A self-referral tool for patients with chronic back pain may be a feasible solution for identifying axial spondyloarthritis, ...

By using a mobile app that captures high-quality photos of the skin, primary care clinicians may manage many skin issues ...

Older Americans with metastatic breast, colorectal, lung, or prostate cancer are spending an increasing amount of time in the ...

Early and sustained ctDNA clearance in early breast cancer treated with neoadjuvant HER2-targeted therapy tracks closely with pathologic complete response to treatment and 3-year outcomes.

A nurse practitioner-led remote patient monitoring program improves glycemic control in uninsured patients with diabetes ...

Dr Suchitra Sundaram shares key highlights on frontline time limited and all oral regimens producing deep MRD responses, ...

The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting ...

The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.

Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a ...

Phase 3 studies point to sustained disease control in patients who remain symptomatic despite standard therapies.

The recommendation addresses a long-standing treatment gap for patients facing bladder removal after standard therapy fails.